Boston Scientific (NYSE:BSX) said today that it built out its biliary offering with the acquisition of endoscope maker EMcision for an undisclosed amount. London- and Montreal-based EMcision makes the Habib EndoHPB probe, which is designed to coagulate tissue in the gastrointestinal tract in treating pancreaticobiliary cancers. Marlborough, Mass.-based Boston Scientific said the probe has 510(k) clearance […]